Literature DB >> 300256

Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells.

A W Burgess, E M Wilson, D Metcalf.   

Abstract

Medium conditioned by human placental tissue was found to stimulate granulocytic and monocytic colony formation by human marrow cells in semisolid agar cultures. The colony-stimulating activity of unfractionated conditioned medium was equivalent to the activity of standard peripheral blood underlayers. Placentas were a reliable source of active material, and one placenta provided enough material to stimulate 5,000-10,000 cultures of normal or leukemic cells. The colony-stimulating factor in human placental conditioned medium (CSFHPCM) was concentrated and purified 1800-fold using ammonium sulfate precipitation, calcium phosphate gel absorption, DEAE-cellulose batch absorption, gel filtration on Sephadex G-150, and polyarcylamide gel gel electrophoresis. The active factor behaved on gel filtration as a macromolecule with an apparent molecular weight of 30,000 daltons. The active factor in placental conditioned medium was not dependent on the presence of adherent marrow cells with endogenous colony-stimulating activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300256

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  59 in total

1.  A simple elimination of clonogenic tumor cells from human bone marrow in vitro by heat: its application to autologous bone marrow transplantation for B-cell lymphoma.

Authors:  Y Moriyama; T Goto; S Hashimoto; T Furukawa; K Kishi; M Takahashi; A Shibata
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

2.  Mycobacterium bovis BCG-induced human T-cell clones from BCG-vaccinated healthy subjects: antigen specificity and lymphokine production.

Authors:  A S Mustafa; G Kvalheim; M Degre; T Godal
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

3.  Simple method for granulocyte-macrophage cell culture and staining in soft agar: comparison with a standard research technique.

Authors:  K Hyde; A J Steed; H Lenehan; M J Saunders; J T Richards; J A Lin Yin; C G Geary
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

4.  Acute nonlymphocytic leukemia (M2) with chromosome abnormality trisomy 4 developing eight years after radiation therapy for breast cancer.

Authors:  S Yokota; M Taniwaki; T Okuda; T Maekawa; K Nishida; S Misawa; T Takino; T Abe; Y Urata
Journal:  Blut       Date:  1989-01

5.  Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.

Authors:  Philippe Hernigou; Matthieu Trousselier; François Roubineau; Charlie Bouthors; Nathalie Chevallier; Helene Rouard; Charles Henri Flouzat-Lachaniette
Journal:  Int Orthop       Date:  2016-03-01       Impact factor: 3.075

6.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Colony-stimulating factor (CSF) radioimmunoassay: detection of a CSF subclass stimulating macrophage production.

Authors:  E R Stanley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

8.  In vitro characterization of the myelotoxicity of cyclopentenyl cytosine.

Authors:  D A Volpe; D L Du; C K Grieshaber; M J Murphy
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

9.  The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines.

Authors:  D H Vesole; G E Moore
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

10.  In vitro suppression of myelopoiesis by adherent murine splenocytes in experimental disseminated histoplasmosis.

Authors:  C W Caldwell; Y W Yesus; R F Sprouse
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.